Identification of the Ki-1 antigen (CD30) as a novel therapeutic target in systemic mastocytosis

The Ki-1 antigen (CD30) is an established therapeutic target in patients with Hodgkin lymphoma and anaplastic large-cell lymphoma. We have recently shown that CD30 is expressed abundantly in the cytoplasm of neoplastic mast cells (MCs) in patients with advanced systemic mastocytosis (SM). In the cur...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood
Main Authors: Blatt, Katharina, Cerny-Reiterer, Sabine, Schwaab, Juliana, Sotlar, Karl, Eisenwort, Gregor, Stefanzl, Gabriele, Hoermann, Gregor, Mayerhofer, Matthias, Schneeweiss, Mathias, Knapp, Sylvia, Rülicke, Thomas, Hadzijusufovic, Emir, Bauer, Karin, Smiljkovic, Dubravka, Willmann, Michael, Reiter, Andreas, Horny, Hans-Peter, Valent, Peter
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2015
Assuntos:
Myeloid Neoplasia
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4692143/
https://ncbi.nlm.nih.gov/pubmed/26486787
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2015-03-637728
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados